Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.

On paper it sounds great: no more pigs being susceptible for PRRS. No more diseased pigs, no more suffering and considerable efficiency gains. Made ...

Honeybee populations facing severe challenges are now being helped by the development of a bee superfood using technology developed in the Bay Area.

The surgeons at Guangzhou Medical University performed this ground-breaking procedure, transplanting the left lung of a specially modified pig into a 39-year-old man who had been declared brain dead a ...

A bacterial work-around developed by UC Davis plant scientists aims to reduce pollution and lower costs for farmers.

Hongene to supply exNA oligonucleotide technology under new licensing deal SINGAPORE (August 26th, 2025) – Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) ...

Gene editing like CRISPR may reverse age-related genetic damageStem cell and exosome therapies aim to regenerate aging tissuesAnti-ageing strategies ...

This year, headlines in the cell and gene therapy landscape have so far been dominated by Sarepta. The biotech’s Duchenne ...

Hongene enters licensing pact with UMass Chan Medical School to produce & supply exNA monomers and exNA-modified oligonucleotides for research use: Singapore Thursday, August 28, ...

RNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.

Researchers have used a gene-editing technology called TALENs (transcription activator-like effector nucleases) to precisely and permanently disable the hepatitis B virus’s hidden genetic material.